AEF0217 First-in-Human Phase I Study in 3 Parts (Single and Multiple Ascending Doses, and Food Effect) in Healthy Subjects.

NCT05170737 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety, Tolerability, Pharmacokinetics of AEF0217

Interventions

DRUG: AEF0217
DRUG: Placebo

Sponsor

Aelis Farma

Collaborators

[object Object]